TY - JOUR
T1 - Sixty percent of patients with rheumatoid arthritis in Japan have used dietary supplements or health foods
AU - Ikuyama, Shoichiro
AU - Imamura-Takase, Emiko
AU - Tokunaga, Shoji
AU - Oribe, Motohiro
AU - Nishimura, Junji
N1 - Funding Information:
Acknowledgments This work was supported in part by Grant-in-Aid for Scientific Research, Japan Society for the Promotion of Science.
PY - 2009
Y1 - 2009
N2 - We conducted a survey on the use of dietary supplements and health foods (DS/HF) in definite rheumatoid arthritis (RA) patients treated by RA specialists. Among 296 patients (male 48, female 248), 179 patients (60.5%) had experience of DS/HF use. Prevalence of DS/HF use was significantly higher in female than in male patients (63.7% versus 43.8%). Overall, patients who have used DS/HF were significantly younger than those who have not used; it was particularly notable in female patients. The proportion of current users was significantly higher in those less than 5 years from diagnosis than those who had been diagnosed for 5 years or more. Products of herbs or algae (44.1%) and components of cartilage (40.8%) were the most popular DS/HF. Primary sources of product information were family members or friends (56.4%) and advertisements in the mass media (34.1%). Of the users, 73.7% did not disclose DS/HF use to their physicians. The users expected alleviation of the symptoms (35.2%) and improvement of health (34.6%). However, 59.2% of the users were unsure of the benefits. In conclusion, physicians should be aware of the high prevalence of DS/HF usage in patients with RA in Japan.
AB - We conducted a survey on the use of dietary supplements and health foods (DS/HF) in definite rheumatoid arthritis (RA) patients treated by RA specialists. Among 296 patients (male 48, female 248), 179 patients (60.5%) had experience of DS/HF use. Prevalence of DS/HF use was significantly higher in female than in male patients (63.7% versus 43.8%). Overall, patients who have used DS/HF were significantly younger than those who have not used; it was particularly notable in female patients. The proportion of current users was significantly higher in those less than 5 years from diagnosis than those who had been diagnosed for 5 years or more. Products of herbs or algae (44.1%) and components of cartilage (40.8%) were the most popular DS/HF. Primary sources of product information were family members or friends (56.4%) and advertisements in the mass media (34.1%). Of the users, 73.7% did not disclose DS/HF use to their physicians. The users expected alleviation of the symptoms (35.2%) and improvement of health (34.6%). However, 59.2% of the users were unsure of the benefits. In conclusion, physicians should be aware of the high prevalence of DS/HF usage in patients with RA in Japan.
UR - http://www.scopus.com/inward/record.url?scp=67349175362&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67349175362&partnerID=8YFLogxK
U2 - 10.1007/s10165-009-0156-2
DO - 10.1007/s10165-009-0156-2
M3 - Article
C2 - 19255828
AN - SCOPUS:67349175362
SN - 1439-7595
VL - 19
SP - 253
EP - 259
JO - Modern Rheumatology
JF - Modern Rheumatology
IS - 3
ER -